Interleukin-19 is cardioprotective in dominant negative cyclic adenosine monophosphate response-element binding protein-mediated heart failure in a sex-specific manner.

Bruns, Danielle R; Ghincea, Alexander R; Ghincea, Christian V; Azuma, Yasu-Taka; Watson, Peter A; Autieri, Michael V; Walker, Lori A

Bruns, Danielle R; Ghincea, Alexander R; Ghincea, Christian V; Azuma, Yasu-Taka; Watson, Peter A; Autieri, Michael V; Walker, Lori A.

Afiliación

Bruns DR; Division of Cardiology, Department of Medicine, University of Colorado-Denver, Aurora, CO 80045, United States.
Ghincea AR; Division of Cardiology, Department of Medicine, University of Colorado-Denver, Aurora, CO 80045, United States.
Ghincea CV; Division of Cardiology, Department of Medicine, University of Colorado-Denver, Aurora, CO 80045, United States.
Azuma YT; Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science, Osaka 599-8351, Japan.
Watson PA; Department of Medicine and Endocrinology, University of Colorado-Denver, Aurora, CO 80045, United States.
Autieri MV; Independence Blue Cross Cardiovascular Research Center, Department of Physiology, Temple University School of Medicine, Philadelphia, PA 19122, United States.
Walker LA; Division of Cardiology, Department of Medicine, University of Colorado-Denver, Aurora, CO 80045, United States.

World J Cardiol ; 9(8): 673-684, 2017 Aug 26.

Article en En | MEDLINE | ID: mdl-28932356

Palabras clave

Cardiac dysfunction; Heart failure; Interleukin-19; Sex differences

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Cardiol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google